HK Stock MarketDetailed Quotes

UNI MEDICAL (02666)

Watchlist
  • 5.580
  • 0.0000.00%
Market Closed May 15 16:07 CST
11.24BMarket Cap4.70P/E (TTM)

UNI MEDICAL (02666) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
9.34%14.94B
15.87%7.58B
0.10%13.66B
-2.91%6.54B
13.06%13.65B
17.98%6.74B
21.78%12.07B
14.07%5.71B
16.35%9.91B
24.44%5.01B
Operating income
9.34%14.94B
15.87%7.58B
0.10%13.66B
-2.91%6.54B
13.06%13.65B
17.98%6.74B
21.78%12.07B
14.07%5.71B
16.35%9.91B
24.44%5.01B
Cost of sales
-9.24%-9.91B
-16.33%-4.98B
0.07%-9.07B
4.19%-4.28B
-19.78%-9.08B
-34.05%-4.47B
-32.62%-7.58B
-26.01%-3.33B
-15.05%-5.71B
-14.44%-2.64B
Operating expenses
-9.24%-9.91B
-16.33%-4.98B
0.07%-9.07B
4.19%-4.28B
-19.78%-9.08B
-34.05%-4.47B
-32.62%-7.58B
-26.01%-3.33B
-15.05%-5.71B
-14.44%-2.64B
Gross profit
9.54%5.03B
14.99%2.6B
0.44%4.59B
-0.40%2.26B
1.73%4.57B
-4.52%2.27B
7.02%4.49B
0.72%2.38B
18.16%4.2B
37.92%2.36B
Selling expenses
3.45%-362.45M
12.23%-158.97M
5.48%-375.39M
-13.36%-181.12M
10.06%-397.17M
29.24%-159.77M
4.42%-441.6M
13.38%-225.79M
-21.46%-462.01M
-44.40%-260.68M
Administrative expenses
-8.04%-1.44B
-21.60%-749.22M
-14.16%-1.33B
-12.42%-616.16M
-27.84%-1.17B
-24.37%-548.08M
-23.55%-914M
-15.97%-440.69M
-20.51%-739.75M
-48.18%-380.02M
Impairment and provision
-2.58%-331.32M
55.55%-48.49M
-68.13%-322.98M
-14.90%-109.08M
37.46%-192.1M
31.00%-94.93M
3.49%-307.14M
19.88%-137.59M
-28.61%-318.24M
-44.40%-171.73M
-Other impairment is provision
-2.58%-331.32M
55.55%-48.49M
-68.13%-322.98M
-14.90%-109.08M
37.46%-192.1M
31.00%-94.93M
3.49%-307.14M
19.88%-137.59M
-28.61%-318.24M
-44.40%-171.73M
Operating interest expense
----
----
----
----
----
----
----
-5.61%-13.77M
4.67%-29.13M
6.82%-13.04M
Special items of operating profit
-45.55%202.37M
-52.96%126.98M
338.64%371.67M
154.68%269.96M
179.86%84.73M
265.97%106M
-484.00%-106.1M
8.48%-63.86M
-61.60%27.63M
-242.80%-69.78M
Operating profit
5.67%3.1B
8.97%1.77B
1.12%2.93B
3.25%1.63B
6.36%2.9B
5.15%1.58B
1.77%2.73B
2.08%1.5B
13.78%2.68B
30.69%1.47B
Financing cost
-36.75%-69.35M
-39.10%-31.14M
-29.85%-50.71M
-32.37%-22.39M
-9.56%-39.05M
---16.91M
---35.65M
----
----
----
Share of profits of associates
-60.25%-8.76M
62.76%-797K
22.66%-5.47M
38.02%-2.14M
-59,008.33%-7.07M
-3,736.67%-3.45M
-93.75%12K
-168.70%-90K
-26.72%192K
173.60%131K
Share of profit from joint venture company
-101.03%-331K
-100.68%-107K
138.17%32.03M
82.02%15.78M
-0.01%13.45M
46.16%8.67M
-1.63%13.45M
-15.32%5.93M
23.35%13.67M
44.54%7M
Earning before tax
3.85%3.02B
7.58%1.74B
1.43%2.91B
3.46%1.62B
6.03%2.87B
3.97%1.56B
0.43%2.7B
1.98%1.5B
13.82%2.69B
30.79%1.48B
Tax
-8.13%-701.56M
-10.80%-406.09M
2.75%-648.79M
0.87%-366.5M
-8.07%-667.14M
-12.57%-369.72M
6.66%-617.33M
6.16%-328.44M
-20.00%-661.34M
-30.98%-349.99M
After-tax profit from continuing operations
2.62%2.32B
6.63%1.34B
2.69%2.26B
4.81%1.25B
5.42%2.2B
1.56%1.19B
2.73%2.09B
4.52%1.18B
11.94%2.03B
30.73%1.13B
Earning after tax
2.62%2.32B
6.63%1.34B
2.69%2.26B
4.81%1.25B
5.42%2.2B
1.56%1.19B
2.73%2.09B
4.52%1.18B
11.94%2.03B
30.73%1.13B
Minority profit
-29.63%108.64M
-3.52%76.42M
73.98%154.38M
44.28%79.21M
-29.65%88.74M
7.30%54.9M
52.44%126.13M
28.02%51.17M
23.91%82.74M
124.84%39.97M
Special items of profit attributable to shareholders
-27.73%52.19M
-14.15%30.67M
-19.24%72.22M
-16.51%35.73M
25.23%89.42M
19.44%42.79M
-36.53%71.4M
0.64%35.83M
12.95%112.5M
-28.51%35.6M
Profit attributable to shareholders
6.15%2.16B
7.99%1.23B
0.54%2.03B
3.66%1.14B
7.02%2.02B
0.71%1.1B
2.90%1.89B
3.75%1.09B
11.39%1.84B
32.34%1.05B
Basic earnings per share
5.61%1.13
8.33%0.65
0.00%1.07
3.45%0.6
7.00%1.07
0.00%0.58
1.01%1
1.75%0.58
3.13%0.99
23.91%0.57
Diluted earnings per share
5.88%1.08
8.77%0.62
3.03%1.02
5.56%0.57
6.45%0.99
1.89%0.54
2.20%0.93
0.00%0.53
-5.21%0.91
15.22%0.53
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
ShinWing Certified Public Accountants (Hong Kong) Limited
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 9.34%14.94B15.87%7.58B0.10%13.66B-2.91%6.54B13.06%13.65B17.98%6.74B21.78%12.07B14.07%5.71B16.35%9.91B24.44%5.01B
Operating income 9.34%14.94B15.87%7.58B0.10%13.66B-2.91%6.54B13.06%13.65B17.98%6.74B21.78%12.07B14.07%5.71B16.35%9.91B24.44%5.01B
Cost of sales -9.24%-9.91B-16.33%-4.98B0.07%-9.07B4.19%-4.28B-19.78%-9.08B-34.05%-4.47B-32.62%-7.58B-26.01%-3.33B-15.05%-5.71B-14.44%-2.64B
Operating expenses -9.24%-9.91B-16.33%-4.98B0.07%-9.07B4.19%-4.28B-19.78%-9.08B-34.05%-4.47B-32.62%-7.58B-26.01%-3.33B-15.05%-5.71B-14.44%-2.64B
Gross profit 9.54%5.03B14.99%2.6B0.44%4.59B-0.40%2.26B1.73%4.57B-4.52%2.27B7.02%4.49B0.72%2.38B18.16%4.2B37.92%2.36B
Selling expenses 3.45%-362.45M12.23%-158.97M5.48%-375.39M-13.36%-181.12M10.06%-397.17M29.24%-159.77M4.42%-441.6M13.38%-225.79M-21.46%-462.01M-44.40%-260.68M
Administrative expenses -8.04%-1.44B-21.60%-749.22M-14.16%-1.33B-12.42%-616.16M-27.84%-1.17B-24.37%-548.08M-23.55%-914M-15.97%-440.69M-20.51%-739.75M-48.18%-380.02M
Impairment and provision -2.58%-331.32M55.55%-48.49M-68.13%-322.98M-14.90%-109.08M37.46%-192.1M31.00%-94.93M3.49%-307.14M19.88%-137.59M-28.61%-318.24M-44.40%-171.73M
-Other impairment is provision -2.58%-331.32M55.55%-48.49M-68.13%-322.98M-14.90%-109.08M37.46%-192.1M31.00%-94.93M3.49%-307.14M19.88%-137.59M-28.61%-318.24M-44.40%-171.73M
Operating interest expense -----------------------------5.61%-13.77M4.67%-29.13M6.82%-13.04M
Special items of operating profit -45.55%202.37M-52.96%126.98M338.64%371.67M154.68%269.96M179.86%84.73M265.97%106M-484.00%-106.1M8.48%-63.86M-61.60%27.63M-242.80%-69.78M
Operating profit 5.67%3.1B8.97%1.77B1.12%2.93B3.25%1.63B6.36%2.9B5.15%1.58B1.77%2.73B2.08%1.5B13.78%2.68B30.69%1.47B
Financing cost -36.75%-69.35M-39.10%-31.14M-29.85%-50.71M-32.37%-22.39M-9.56%-39.05M---16.91M---35.65M------------
Share of profits of associates -60.25%-8.76M62.76%-797K22.66%-5.47M38.02%-2.14M-59,008.33%-7.07M-3,736.67%-3.45M-93.75%12K-168.70%-90K-26.72%192K173.60%131K
Share of profit from joint venture company -101.03%-331K-100.68%-107K138.17%32.03M82.02%15.78M-0.01%13.45M46.16%8.67M-1.63%13.45M-15.32%5.93M23.35%13.67M44.54%7M
Earning before tax 3.85%3.02B7.58%1.74B1.43%2.91B3.46%1.62B6.03%2.87B3.97%1.56B0.43%2.7B1.98%1.5B13.82%2.69B30.79%1.48B
Tax -8.13%-701.56M-10.80%-406.09M2.75%-648.79M0.87%-366.5M-8.07%-667.14M-12.57%-369.72M6.66%-617.33M6.16%-328.44M-20.00%-661.34M-30.98%-349.99M
After-tax profit from continuing operations 2.62%2.32B6.63%1.34B2.69%2.26B4.81%1.25B5.42%2.2B1.56%1.19B2.73%2.09B4.52%1.18B11.94%2.03B30.73%1.13B
Earning after tax 2.62%2.32B6.63%1.34B2.69%2.26B4.81%1.25B5.42%2.2B1.56%1.19B2.73%2.09B4.52%1.18B11.94%2.03B30.73%1.13B
Minority profit -29.63%108.64M-3.52%76.42M73.98%154.38M44.28%79.21M-29.65%88.74M7.30%54.9M52.44%126.13M28.02%51.17M23.91%82.74M124.84%39.97M
Special items of profit attributable to shareholders -27.73%52.19M-14.15%30.67M-19.24%72.22M-16.51%35.73M25.23%89.42M19.44%42.79M-36.53%71.4M0.64%35.83M12.95%112.5M-28.51%35.6M
Profit attributable to shareholders 6.15%2.16B7.99%1.23B0.54%2.03B3.66%1.14B7.02%2.02B0.71%1.1B2.90%1.89B3.75%1.09B11.39%1.84B32.34%1.05B
Basic earnings per share 5.61%1.138.33%0.650.00%1.073.45%0.67.00%1.070.00%0.581.01%11.75%0.583.13%0.9923.91%0.57
Diluted earnings per share 5.88%1.088.77%0.623.03%1.025.56%0.576.45%0.991.89%0.542.20%0.930.00%0.53-5.21%0.9115.22%0.53
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ShinWing Certified Public Accountants (Hong Kong) Limited--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More